Abstracts tagged "MicroRNA and familial Mediterranean fever"

Abstract Number: 1012 • 2017 ACR/ARHP Annual Meeting
Analysis of microRNAs in Familial Mediterranean Fever
Gil Amarilyo¹, Nir Pillar², Ilan Ben-Zvi³, Daphna Weissglas-Volkov², Jonatan Zalcman², Liora Harel⁴, Avi Livneh³ and Noam Shomron², ¹Schneider Children's Medical Center of Israel, Sackler School of Medicine, Tel Aviv University, Petach Tikva, Israel, ²Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel, ³Chaim Sheba Medical Center, Tel Hashomer, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel, ⁴Schneider Children's Medical Center of Israel, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
Background/Purpose: Familial Mediterranean fever (FMF) is thought to be inherited as an autosomal recessive trait. However, there are frequent deviations from this model. The aim…
Abstract Number: 249 • 2016 ACR/ARHP Annual Meeting
MiR-204-3p Associates with an Increased Level of IL-6 in Familial Mediterranean Fever By Targeting the PIK3 Signaling Pathway
Tomohiro Koga¹, Kiyoshi Migita², Akihiro Yachie³, Yukitaka Ueki⁴, Kazunaga Agematsu⁵, Junya Masumoto⁶, Koh-ichiro Yoshiura⁷, Katsumi Eguchi⁸ and Atsushi Kawakami¹, ¹Unit of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, ²Department of Rheumatology and Clinical Research Center, Nagasaki Medical Center, Omura, Japan, ³Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan, ⁴Rheumatic and Collagen Disease Center, Sasebo Chuo Hospital, Sasebo, Japan, ⁵Department of Infectious Immunology, Shinshu University, Graduate School of Medicine, Shinshu, Japan, ⁶Department of Pathology, Division of Analyticalpathology, Ehime University Graduate School of Medicine, Toon, Japan, ⁷Department of Human Genetics, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, ⁸Department of Rheumatology and Metabolism, Sasebo City General Hospital, Sasebo, Japan
Background/Purpose: Familial Mediterranean fever (FMF) is caused by a number of mutations of the MEFV gene, coding for a protein named pyrin that acts as…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].